Excipients are of vital importance in the process of drug development. A good choice of excipient can lead to the formulation of stable dosage forms. To better meet the increasing demand for ...
As a service provider for custom pharmaceutical formulation projects, CD Formulation announces today that it is able to conduct API-excipient compatibility analysis service for clients across the ...
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is ...
At the 2020 Bio/Pharma Virtual Congress, experts discuss the importance of characterizing excipients to ensure quality, safety, and effective performance. The recent discovery of probable carcinogens ...
One of the major challenges in working with excipients today is understanding, and adjusting to, complexity in materials and formulations. Pharmaceutical manufacturers today contend with such ...
FDA is launching a program to test the safety and suitability of novel inactive ingredients for use in new drugs and biologics. In an important step for modernizing drug formulation and ...
WOBURN, Mass.--(BUSINESS WIRE)--ReForm Biologics, a pharmaceutical technology company developing innovative platforms to improve biologic formulations, expanded its patent portfolio with the issuance ...
To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...
Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Excipients Market: Focus on Application, Formulation, Functionality, Product, Region, and Competitive Landscape - Analysis and ...
The Nutraceutical Excipients Market is being driven by the growing global demand for dietary supplements, functional foods, and fortified nutrition products. Rising consumer focus on preventive ...
Formulation can make or break a development-stage protein drug, and add years of IP protection and value for post-patent molecules. Yet significant disagreement exists on the best time to undertake ...